`

Lyell Immunopharma

Biotechnology Research

Last Updated: November 24, 2025
Revenue
$61.00K
funding-icon Total Funding
$493.00M
Size
51 - 200

Frequently Asked Questions About Lyell Immunopharma

What does Lyell immunopharma do?+

Using living cells to treat and sometimes even cure cancer is one of the most dramatic advances in modern medicine. Patients with hematologic malignancies have been successfully treated with cell therapies. However, these profound results have not yet been achieved in patients with solid tumors, representing approximately 90% of all cancers. At Lyell, our goal is to change that. We are a clinical-stage T-cell reprogramming company advancing a diverse pipeline of cell therapies for solid tumors based on our innovative technologies. We were founded by cell therapy pioneers whose decades of research elevated the broader understanding of T-cell biology and...

What is Lyell immunopharma's industry? +

Lyell immunopharma operates in the Biotechnology research industry.

What is Lyell immunopharma's revenue? +

Lyell immunopharma's revenue is $61.00k

What is Lyell immunopharma's company size? +

Lyell immunopharma has 51 - 200 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.